Vyant Bio Receivables

Vyant Bio (VYNT) currently reports a receivables of $320K as of December 2022. That compares with $430K in the prior-year period — down 25.6% year over year. Use the charts on this page to explore Vyant Bio's receivables history and peer comparisons.

Vyant Bio's receivables decreased from $430K to $320K — a 25.6% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vyant Bio reported $320K in receivables as of December 2022. That compares with $430K in the prior-year period — down 25.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $320K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vyant Bio, and consider following VYNT for alerts when major investors trade the stock.

Vyant Bio is classified in the Healthcare sector. On receivables, it currently shows $320K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VYNT with unrelated industries.